Orencia 250 MG vials
Ended Awarded
- Contract number
- SPE2DB25FCXWD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,949
Award facts
- Contract value 100% obligated
- $11,948.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,948.89 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials. This firm fixed-price, non-competitive delivery order was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's portfolio encompasses a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. Orencia, a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions, represents part of the company's extensive specialty pharmaceutical offerings delivered through the DLA's global pharmaceutical support framework, which enables flexible medical commodity sourcing to support military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DB25FCXWD?
SPE2DB25FCXWD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FCXWD worth?
The government has obligated $11,949 on SPE2DB25FCXWD.
Is contract SPE2DB25FCXWD an order under another contract?
Yes. SPE2DB25FCXWD is a delivery order under SPE2DB24D1205, an indefinite delivery contract.
Was contract SPE2DB25FCXWD competed?
The extent of competition for SPE2DB25FCXWD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award